Participation to include a collaboration with Innominds to develop next-generation surgical sensing capabilities that will reduce preventable surgical errors and complications across the U.S. and globally.
The platform and its associated products will be initially available in the U.S. market, with plans to commercialize globally in 2021. reports Activ Surgical.
